Analytical Data
-
Gene name
TASP1
- Application
-
Alternative Names
TASP1；C20orf13；Threonine aspartase 1
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9H6P5
-
Expression Region
1-233aa
-
AA Sequence
MTMEKGMSSG EGLPSRSSQV SAGKITAKEL ETKQSYKEKR GGFVLVHAGA GYHSESKAKE YKHVCKRACQ KAIEKLQAGA LATDAVTAAL VELEDSPFTN AGMGSNLNLL GEIECDASIM DGKSLNFGAV GALSGIKNPV SVANRLLCEG QKGKLSAGRI PPCFLVGEGA YRWAVDHGIP SCPPNIMTTR FSLAAFKRNK RKLELAERVD TDFMQLKKRR QSSEKENDSG TLD
-
Molecular Weight
44.4 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TASP1 (Tachykinin-Associated Peptide 1) is a recently identified protein that has garnered attention in the field of molecular biology due to its potentially significant role in various physiological processes. Initially discovered in relation to neuropeptide signaling pathways, TASP1 is thought to regulate cellular communication and response mechanisms within the nervous system. Studies suggest that TASP1 may be involved in neuroinflammation and neurodegenerative diseases, making it a focal point for understanding pathophysiological conditions such as Alzheimer's and Parkinson's disease. The recombinant expression of TASP1 provides a valuable tool for elucidating its functional properties and interactions at a molecular level. By producing TASP1 in a controlled laboratory environment, researchers can investigate its structural characteristics, signaling pathways, and potential therapeutic implications. Current research efforts are directed toward characterizing the biochemical properties of TASP1, assessing its effects on neuronal health, and exploring its potential as a biomarker or a target for drug development. The exploration of TASP1 and its recombinant forms may lead to novel insights into therapeutic strategies for treating neurological disorders.
